返回 Agenda
SLS05 ICH Anniversary: Summary of 30 Years and Future Prospects in S Area with Role of Japan
Session Chair(s)
Yoko Hirabayashi, MD
Division Head
National Institute of Health Sciences, Japan
Kazuto Watanabe, PhD
Translational Research Division Principal Scientist
Chugai pharmaceutical Co, LTD, Japan
Speaker(s)
Kazushige Maki, DVM, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Senior Scientist, Toxicology
Takuya Nishimura, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Principal Reviewer, Office of Cellular and Tissue-based Products
Shigeru Hisada
ASKA Pharmaceutical Co, Ltd , Japan
Innovative Drug Discovery Division
Joy A. Cavagnaro, PhD
Access BIO, United States
President